The Europe Intraoperative Neuromonitoring Market would witness market growth of 5.6% CAGR during the forecast period (2023-2030).
The expanding range of applications for IONM across various surgical specialties has broadened its appeal. Initially prevalent in neurosurgery, IONM is utilized in orthopedic, spinal, otolaryngology, and vascular surgeries. The versatility of IONM in safeguarding different neural structures has led to its integration into a diverse array of surgical disciplines. The economic considerations associated with surgical procedures also influence the adoption of IONM. While the initial investment in IONM technology may be significant, the potential cost savings associated with preventing complications and reducing the need for postoperative interventions make it an economically viable choice for many healthcare institutions.
As patients become more informed about advancements in healthcare, they may actively seek out surgeons and healthcare facilities that offer IONM as part of their surgical protocols. The growing awareness among patients about the potential benefits of IONM creates a demand-driven incentive for its adoption by healthcare providers. The detection and preservation of important neural structures during surgery is one of the main applications of IONM. In procedures involving the brain, spinal cord, peripheral nerves, and cranial nerves, IONM helps surgeons precisely locate and navigate these structures, reducing the risk of unintentional damage.
As per Destatis, 2020, since younger birth cohorts also show decreasing numbers of people, over 65-year-olds make up an ever-larger proportion of the total population over time. It rose from 15% in 1991 to 22 % in 2019. The group of the very old, above 85, is particularly fast growing. Their number increased from 1.2 million in 1991 to 2.4 million in 2019. Similarly, according to a report on the French aging policy published by the UN, as in other European countries, France faces a continuous and significant increase in elderly people. The nation had 15 million people aged more than 60 in France in 2012, expected to reach 24 million in 2060. Hence, all these factors will uplift the regional market’s expansion in the coming years.
The Germany market dominated the Europe Intraoperative Neuromonitoring Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $469.8 million by 2030. The UK market is exhibiting a CAGR of 4.7% during (2023 - 2030). Additionally, The France market would experience a CAGR of 6.4% during (2023 - 2030).
Free Valuable Insights: The Global Intraoperative Neuromonitoring Market will Hit USD 7 Billion by 2030, at a CAGR of 6%
Based on Source Type, the market is segmented into Insourced Monitoring, and Outsourced Monitoring. Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCs). Based on Products & Services, the market is segmented into Services, Systems, and Accessories. Based on Application, the market is segmented into Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, and Others. Based on Modality, the market is segmented into Electromyography (EMG), Electroencephalography (EEG), Motor Evoked Potentials (MEPs), Somatosensory Evoked Potentials (SSEPs), Visual Evoked Potentials (VEPs), and Brainstem Auditory Evoked Potentials (BAEPs). Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
By Source Type
By End User
By Products & Services
By Application
By Modality
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
